These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34283087)

  • 1. Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer.
    Todeschini P; Salviato E; Romani C; Raimondi V; Ciccarese F; Ferrari F; Tognon G; Marchini S; D'Incalci M; Zanotti L; Ravaggi A; Odicino F; Sartori E; D'Agostino DM; Samaja M; Romualdi C; Bignotti E
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].
    Zhang P; He M; Zeng Y; Cai X
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):8-16. PubMed ID: 36856205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3.
    Zhang L; Zhang Y; Wang S; Tao L; Pang L; Fu R; Fu Y; Liang W; Li F; Jia W
    Am J Transl Res; 2020; 12(3):875-888. PubMed ID: 32269720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network vulnerability-based and knowledge-guided identification of microRNA biomarkers indicating platinum resistance in high-grade serous ovarian cancer.
    Qi X; Yu C; Wang Y; Lin Y; Shen B
    Clin Transl Med; 2019 Oct; 8(1):28. PubMed ID: 31664600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies.
    Petrillo M; Zannoni GF; Beltrame L; Martinelli E; DiFeo A; Paracchini L; Craparotta I; Mannarino L; Vizzielli G; Scambia G; D'Incalci M; Romualdi C; Marchini S
    Ann Oncol; 2016 Apr; 27(4):625-34. PubMed ID: 26782955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients.
    Petersen PHD; Lopacinska-Jørgensen J; Høgdall CK; Høgdall EV
    Mol Biol Rep; 2023 Dec; 50(12):10235-10247. PubMed ID: 37934368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer.
    Flores-Colón M; Rivera-Serrano M; Reyes-Burgos VG; Rolón JG; Pérez-Santiago J; Marcos-Martínez MJ; Valiyeva F; Vivas-Mejía PE
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways.
    Ma M; Dai J; Tang H; Xu T; Yu S; Si L; Cui C; Sheng X; Chi Z; Mao L; Wu X; Yang L; Yu H; Li S; Lian B; Tang B; Wang X; Yan X; Bai X; Zhou L; Kong Y; Guo J
    Theranostics; 2019; 9(4):945-960. PubMed ID: 30867808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study.
    Benson EA; Skaar TC; Liu Y; Nephew KP; Matei D
    PLoS One; 2015; 10(10):e0141279. PubMed ID: 26485143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of synovial fluid microRNA signature in knee osteoarthritis: differentiating early- and late-stage knee osteoarthritis.
    Li YH; Tavallaee G; Tokar T; Nakamura A; Sundararajan K; Weston A; Sharma A; Mahomed NN; Gandhi R; Jurisica I; Kapoor M
    Osteoarthritis Cartilage; 2016 Sep; 24(9):1577-86. PubMed ID: 27143365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
    Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlations between miRNAs and TGF-β1 in tumor microenvironment of esophageal squamous cell cancer].
    Zhu L; Jin L; Jiang R; Wang Q; Jiang J; Mao C; Chen D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 May; 29(5):524-8. PubMed ID: 23643275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-509-3p enhances platinum drug sensitivity in ovarian cancer.
    Niu L; Ni H; Hou Y; Du Q; Li H
    Gene; 2019 Feb; 686():63-67. PubMed ID: 30408550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells.
    Arrighetti N; Cossa G; De Cecco L; Stucchi S; Carenini N; Corna E; Gandellini P; Zaffaroni N; Perego P; Gatti L
    Toxicol Appl Pharmacol; 2016 Nov; 310():9-19. PubMed ID: 27554045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-23a-3p Is Upregulated in Plasma Exosomes of Bulbar-onset ALS Patients and Targets ERBB4.
    Liu Y; Ding M; Pan S; Zhou R; Yao J; Fu R; Yu H; Lu Z
    Neuroscience; 2023 Aug; 524():65-78. PubMed ID: 37290686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.
    Prahm KP; Høgdall C; Karlsen MA; Christensen IJ; Novotny GW; Høgdall E
    PLoS One; 2018; 13(11):e0207319. PubMed ID: 30475821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
    Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
    Oncotarget; 2017 Oct; 8(50):87837-87847. PubMed ID: 29152124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-23a-3p and miR-23a-5p target CiGadd45ab to modulate inflammatory response and apoptosis in grass carp.
    Fang Y; Xu XY; Shen Y; Li J
    Fish Shellfish Immunol; 2020 Mar; 98():34-44. PubMed ID: 31883472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Pathol Res Pract; 2019 Apr; 215(4):660-667. PubMed ID: 30606659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.